Brevia Health provides straightforward public affairs advice and support to organisations operating in the highly regulated UK healthcare sector. We advise companies that range from global pharmaceutical companies to innovative start-ups.
Our consultants have experience in a broad range of areas including electronic patient records, in vitro diagnostics, medical devices, pharmaceuticals, remote monitoring, patient groups, patient information, genomics, and social care.
An area of particular specialism is IT Healthcare where we have supported the UK’s largest EPR supplier to win significant contracts in the UK. Following the demise of the National Programme, the UK marketplace has been reinvigorated and new entrants are appearing. This provides significant opportunities for IT providers both new and established to win contracts in the NHS.
This week, the Government stepped in to save the regional airline, Flybe, from collapse. Having won a majority by gaining votes in nearly every region of the UK, the intervention symbolises Boris Johnson’s stated desire to ‘level up’ the country.
On 14 January 2020, the European Union (UN) unveiled plans for €1 trillion in sustainable investments over the coming decade. The investment is designed to make the EU climate-neutral by 2050, however, the transition fund money under the plan will not finance the construction of nuclear power plants.
Following defeat last week, Jeremy Corbyn announced he would not stand as Labour Party leader at the next general election. The Labour Party will have to elect another leader and the next contest will be the first to take place under new rules established in 2018.
WORK WITH US
A track record in delivering results
Brevia delivers tailored support to businesses operating in the health sector. Our three-step process offers a straightforward approach to delivering crucial intelligence, strategic advice and stakeholder engagement.